EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access

The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review

Joana Catarina Costa Martins iD, Ana Rosa Cristão Afonso Lucas iD, Joana Margarida Meneses Costa iD

Revista Brasileira de Ginecologia e Obstetrícia · 26.07.2024 · 46

DOI: 10.61622/rbgo/2024rbgo49 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Revista Brasileira de Ginecologia e Obstetrícia, erschienen am 26.07.2024. Verfasst von Joana Catarina Costa Martins und 2 weiteren Autor:innen. Beteiligte Einrichtung: USF São Vicente Porto Portugal Family Medicine, USF São Vicente, Porto, Portugal. Hauptthemen laut MEDLINE: Sexual Dysfunction, Physiological, Sildenafil Citrate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The purpose of this study was to analyze the available evidence regarding the efficacy of iPDE5 in the treatment of female sexual dysfunction (FSD).

Methods

A comprehensive literature search was conducted in March 2023 through the main scientific databases.

Results

A total of 53 articles were identified, out of which, 6 met the predefined inclusion criteria. All of these were randomized controlled trials. Among the included studies, 4 demonstrated the effectiveness of sildenafil in improving sexual response and addressing FSD, while 2 studies failed to establish its efficacy in this context.

Conclusion

Overall, the efficacy of sildenafil in the treatment of FSD remains controversial and inconclusive based on the available evidence. Further research is necessary to clarify the therapeutic potential of iPDE5 in addressing FSD and to better understand the factors that influence treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sexual Dysfunction, PhysiologicalSildenafil CitrateHumansFemalePhosphodiesterase 5 InhibitorsRandomized Controlled Trials as TopicPhosphodiesterase InhibitorsTreatment Outcome

Stichwörter der Autor:innen

FemaleLibidoPhosphodiesterase inhibitorSexual dysfunctionSildenafil

Substanzen

Sildenafil CitratePhosphodiesterase 5 InhibitorsPhosphodiesterase Inhibitors

Autor:innen und Institutionen

  • USF São Vicente Porto Portugal Family Medicine, USF São Vicente, Porto, Portugal.
  • USF Renascer Porto Portugal Family Medicine, USF Renascer, Porto, Portugal.
  • USF Valbom Porto Portugal Family Medicine, USF Valbom, Porto, Portugal.

ORCID-Profile: Joana Catarina Costa Martins, Ana Rosa Cristão Afonso Lucas, Joana Margarida Meneses Costa

Zitieren

APA

Martins, J. C. C., Lucas, A. R. C. A., & Costa, J. M. M. (2024). The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review. Revista Brasileira de Ginecologia e Obstetrícia, 46. https://doi.org/10.61622/rbgo/2024rbgo49

Vancouver

Martins JCC, Lucas ARCA, Costa JMM. The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review. Revista Brasileira de Ginecologia e Obstetrícia. 2024;46. doi:10.61622/rbgo/2024rbgo49

BibTeX
@article{Martins2024,
  author = {Martins, Joana Catarina Costa and Lucas, Ana Rosa Cristão Afonso and Costa, Joana Margarida Meneses},
  title = {The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review},
  journal = {Revista Brasileira de Ginecologia e Obstetrícia},
  year = {2024},
  volume = {46},
  doi = {10.61622/rbgo/2024rbgo49}
}
Kostenlos starten →